Compare BWEN & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BWEN | NRXP |
|---|---|---|
| Founded | N/A | 2015 |
| Country | United States | United States |
| Employees | N/A | 29 |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 105.8M | 99.2M |
| IPO Year | 2009 | N/A |
| Metric | BWEN | NRXP |
|---|---|---|
| Price | $4.34 | $3.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $6.00 | ★ $38.25 |
| AVG Volume (30 Days) | 478.3K | ★ 932.4K |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 360.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $146,785,000.00 | N/A |
| Revenue This Year | N/A | $2,547.84 |
| Revenue Next Year | $17.37 | $1,591.73 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.84 | $1.65 |
| 52 Week High | $5.40 | $5.06 |
| Indicator | BWEN | NRXP |
|---|---|---|
| Relative Strength Index (RSI) | 50.41 | 55.74 |
| Support Level | $4.10 | $1.83 |
| Resistance Level | $4.90 | $4.20 |
| Average True Range (ATR) | 0.45 | 0.32 |
| MACD | -0.09 | -0.01 |
| Stochastic Oscillator | 25.67 | 80.43 |
Broadwind Inc is a precision manufacturer of structures, equipment, and components for clean technology and other specialized applications. The company provides technologically high-value products to customers with complex systems and stringent quality standards that operate in the energy, mining, and infrastructure sectors in the United States of America. Its capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treatment, CNG decompression, precision machining, assembly, engineering, and packaging solutions, among others. The company operates in four reportable segments: Heavy Fabrications, which generates the maximum revenue, Gearing, Industrial Solutions, and Corporate.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.